BoYu13ChenzeLi123YangSun1Dao WenWang14 1 Division of Cardiology, Department of Internal Medicine and Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2 Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan 430030, China Received 27 August 2020, Revised 4 October […]

Maria Carlota Dao1*†, Nataliya Sokolovska1, Rémi Brazeilles2, Séverine Affeldt1, Véronique Pelloux1, Edi Prifti3,4, Julien Chilloux5, Eric O. Verger1, Brandon D. Kayser1, Judith Aron-Wisnewsky1,6, Farid Ichou7, Estelle Pujos-Guillot8, Lesley Hoyles5,9, Catherine Juste10, Joël Doré10, Marc-Emmanuel Dumas5, Salwa W. Rizkalla1, Bridget A. Holmes2, Jean-Daniel Zucker3,4, Karine Clément1,6* and the MICRO-Obes Consortium‡ 1Sorbonne University, French National Institute for Health and Medical Research, NutriOmics Unit, Institute of Cardiometabolism and Nutrition, Paris, France 2Danone Nutricia Research, Palaiseau, France 3Institute of […]

Yajie Guo*, Zihua Huang, Dan Sang, Qiong Gao and Qingjiao Li* The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen, China Type 2 diabetes (T2D) is a rapidly growing epidemic, which leads to increased mortality rates and health care costs. Nutrients (namely, carbohydrates, fat, protein, mineral substances, and vitamin), sensing, and management are central to metabolic homeostasis, therefore presenting a […]

Bo Yu 1, Chenze Li 2, Yang Sun 1, Dao Wen Wang 3 Affiliations expand PMID: 33248471 PMCID: PMC7682421 DOI: 10.1016/j.cmet.2020.11.014 Free PMC article Abstract COVID-19 caused by SARS-COV-2 infection can lead to multi-organ injuries and significant mortality in severe and critical patients, especially among those individuals with type 2 diabetes (T2D) as a comorbidity. While attenuated mortality was observed with aggressive glucose control, it was […]

Too often our medical treatments “manage” type 2 diabetes. But we can and should do better. A new paper calls to attention how we should be fighting to reverse type 2 diabetes or put it into remission. The best part is that we don’t need expensive drugs to do it. We can do it with […]

For decades researchers have been working with varied success to understand and intercept the signalling pathways involved in diabetes and its co-morbidities, with the ultimate goal to reverse disease progression rather than just slowing it down. Now, new evidence suggests that TRPV1-expressing sensory neurons may play a pivotal role in initiating and maintaining the inflammatory […]

With more than 120 million Americans now living with diabetes or pre-diabetes—placing them at higher risk of complications from COVID-19—getting the real facts about diet, exercise, and effectively monitoring and managing your glucose levels is more critical than ever. Which eating program is most effective at managing glucose levels? Does diet or exercise have a […]

Dr. Mariela Glandt shares her experience as a diabetes specialist and tells us how to reverse diabetes. Since she now understands the proper diet for those with diabetes, she rarely prescribes those medications. We also explore the role that metabolic health plays in the Covid-19 pandemic. Table of contents: 0:00 Introduction 3:05 Welcome, Dr. Mariela […]

A major health insurer institutes a new program using CGM and lifestyle interventions to help patients with type 2 diabetes. This could be a great sign of things to come! Read more https://www.dietdoctor.com/top-health-insurer-offers-new-lifestyle-for-patients-with-type-2-diabetes Subscribe to our channel if you don’t want to miss any of our videos: https://www.youtube.com/c/DietDoctorVideo?sub_confirmation=1 About us: DietDoctor.com is the world’s number […]

Covance and the Cardio Renal Society of America (CRSA) are pleased to present this third webinar as part of our Cardio Renal Series, co-hosted by Dr. Barbara Gillespie (Therapeutic Head of Nephrology, Covance) and Dr. Peter McCullough (cardiologist and President, CRSA). They will co-host Dr. Katherine Tuttle, an endocrinologist and nephrologist, who has served in […]

Listen as Dr Stephen Hull, an endocrinologist from Saint John, Canada, explains the importance of considering the heart when treating people with type 2 diabetes and the changing treatment landscape in this area .

Watch as Dr Stephen Hull highlights the common misconceptions surrounding type 2 diabetes and heart disease, and provides practical advice on key steps to help people living with diabetes protect their heart .

What do the latest diabetes and CV treatment guidelines mean for HCPs? Watch cardiologist Dr. Javed Butler and endocrinologist Dr. Rachel Pessah-Pollack discuss their “team sport” approach to CV risk reduction in their type 2 diabetes patients.

Dogs are good for heart health. Cardiologists Dr. Javed Butler and Dr. Keith Ferdinand take their four-legged friend, Maggie, for a walk as they discuss the importance of collaboration in diabetes treatment and staying connected to their patients.

Title: Diabetes Epigenome Atlas (DGA) and T2D Knowledge Portal: connected and complementary resources for research on the genomic and genetic basis of T2D Description: T2D Knowledge Portal Platform Workshop & Webinar Series fall installment featuring the Diabetes Epigenome Atlas (DGA). An overview of the resource, including the data and tools within as well as the […]

Prof Alessandro Doria (Harvard Medical School, Boston, MA, US) discuss Genetics and precision medicine: Personalised prevention of cardiovascular disease in type 2 diabetes:Is it possible? Questions : 1. Can you tell us about the ACCORD trial and its importance for paving the way for a personalized prevention of CVD? 2. What were your findings to […]

Future considerations for managing patients with type 2 diabetes and associated cardiovascular risk based on emerging data and clinical recommendations with SGLT2 inhibitors and GLP-1 agonists.

Diabetes has become a disaster with more than 400 million individuals Type 2 Diabetes (T2D) globally. Complications such as diabetic retinopathy, kidney disease and cardiovascular and cerebrovascular diseases pose enormous challenges to the global healthcare system, and global diabetes management costs have reached $800 billion. Scientists and medical experts all over the world have worked […]

Dogs are good for heart health – and recent changes to treatment guidelines reflect a fundamental shift in how HCPs must approach the care of people with type 2 diabetes and cardiovascular disease in order to reduce risk and maintain a healthy heart. Dr. Butler takes a walk with New Orleans native, Dr. Ferdinand and […]

Katherine Tuttle (Nephrologist and Endocrinologist) joins Jay Shubrook (Primary Care Physician) to discuss recommendations on diabetes patient referrals to the nephrology clinic (8:38). View more on Medicine Matters diabetes: http://bit.ly/2Vq1eW5 More on diabetic kidney disease: http://bit.ly/DKDmmd

More than 20 years ago, Roy Taylor, MD, began working to further understand the pathogenesis of hepatic insulin resistance in people with type 2 diabetes. It became clear that the main determinant was the amount of fat in the liver.

Insight regarding the link between metabolic syndrome and the risk for type 2 diabetes and cardiovascular disease.

Expert colleagues react to the benefits demonstrated through data with the use of GLP-1 agonists for the treatment of type 2 diabetes and explore how the various options work.

Recommendations for initiating therapy with a GLP-1 receptor agonist in a 46-year-old woman with type 2 diabetes as well as hypertension and hypercholesterolemia, and insight regarding patient and physician misconceptions surrounding the prescribing and utilization of injectables.

Two weeks ago, the Low Carb Denver 2019 conference came to an end. Here’s our third posted presentation, after Gary Taubes’ and Dr. Andreas Eenfeldt, and this one is with the amazing Dr. Sarah Hallberg. What is the best approach to type 2 diabetes reversal? In this presentation, Sarah takes us on a deep-dive into […]

For decades, the medical world has seen type 2 diabetes as a chronic condition that we can only hope to manage with medications to delay inevitable complications. Dr. Hallberg and her colleagues at Virta Health have completely changed that paradigm by showing us that we can reverse type 2 diabetes and we can allow patients […]

The Boehringer Ingelheim representative discusses how the future of empagliflozin research should shape out.

This is an overview of an article entitled “Birthweight, Type 2 Diabetes and Cardiovascular Disease: Addressing the Barker Hypothesis with Mendelian Randomization”, published in the June 2018 issue of Circulation: Genomic and Precision Medicine.

Dr. David Unwin is GP based in Southport in the United Kingdom. After 25 years of attempting to treat diabetes by conventional methods, Dr. Unwin stumbled upon the website for patients with diabetes – www.diabetes.co.uk From this revelation, Dr. Unwin now ignores official advice and treats his patients with a low-carbohydrate diet. Since adopting the […]

Quick, impromptu video I did for the BBC on simple, practical tips to help manage and potentially reverse your Type 2 Diabetes. It is important that you see your doctor to discuss any changes you wish to make, particularly if you are on medication. Follow me on: https://www.drchatterjee.co.uk https://www.facebook.com/DrChatterjee/ Tweets by drchatterjeeuk https://www.instagram.com/drchatterjee/

At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th September 2015, Prof Jørgen Rungby of the Gentofte University Hospital, Hellerup, Copenhagen, Denmark, describes the management of Type 2 diabetes and how this is even more complex in acute coronary […]

At a Takeda-sponsored symposium held at the 51st Annual Meeting of the European Association for the Study of Diabetes in Stockholm, Sweden, on the 14th September 2015, Prof Stephen Nicholls of the South Australian Health & Medical Research Institute and University of Adelaide, Adelaide, Australia, describes the control of dysglycaemia in acute coronary syndrome patients […]

Video abstract of original research paper “Determinants of medication adherence among adults with type 2 diabetes mellitus in three Malaysian public health clinics: a cross-sectional study” published in the open access journal Patient Preference and Adherence by Chew BH, Hassan NH, Mohd-Sidk S. Abstract: Medication adherence, MA, in adults with type 2 diabetes mellitus, T2D, […]

The management of Type 2 Diabetes (T2D) is complex and challenging. Sodium glucose cotransporter 2 (SGLT2) inhibition offers a different mode of action from other oral glucose lowering treatments. Find out more about SGLT2 inhibition and its potential impact on T2D management.